wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q56594845-E49C77E3-83EB-4DB1-8DFB-A34CD283F30B
Q56594845-E49C77E3-83EB-4DB1-8DFB-A34CD283F30B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56594845-E49C77E3-83EB-4DB1-8DFB-A34CD283F30B
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
P2860
Q56594845-E49C77E3-83EB-4DB1-8DFB-A34CD283F30B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56594845-E49C77E3-83EB-4DB1-8DFB-A34CD283F30B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e0086eae23c668b2fbed7b5ce51e473c4f07a5a
P2860
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.